In 2015, the project developed by Nagi Bioscience was the first recipient of the SGV 25th Fund.  This fund was created by the SGV board to financially support projects related to the goals of the SGV, that are promotion of the Laboratory Animal Science and the Animal Welfare, and ethical considerations in animal experimentation. Read more about the…

Our Business Plan was awarded as TOP 10, among 108 submitted projects! »Venture» is Switzerland’s premier startup competition, initiative of  ETH Zurich, EPF Lausanne, Knecht Holding, the innovation promotion agency CTI and McKinsey & Company, Switzerland.

This prestigious prize is given annually by the “E. Naef Foundation for in vitro research” (FENRIV), established in 1998. The foundation assists researchers investigating scientific means for restricting the use of vivisection and generally promotes in vitro research. Our team has been awarded for its work on the development of a novel in vitro technology for testing the toxicity of chemical compounds…

Gebert Rüf Stiftung fosters innovations for the benefit of Swiss economy and society, by supporting application-oriented and impact-oriented scientific projects at Swiss universities. The “Nematrix Project”, by Nagi Bioscience, became part of the GRS-supported project portfolio in November 2016.

The EPFL website and the Swiss French Radio (RTS) have covered the publication of our last scientific paper. The article was published in Molecular Neurodegeneration and shows data about the in vivo analysis of the long-term dynamics of protein aggregation in C. elegans at unprecedented resolution.

Our Business Idea (formerly known as Nematrix) was selected by the Jury Committee of >>venture>> 2015,out of a total of 107 submissions, as a TOP 10 winner of the business idea competition! The award ceremony took place at ETH Zurich in June 2015.